{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T17:40:13Z","timestamp":1792172413076,"version":"4.4.0"},"reference-count":259,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T00:00:00Z","timestamp":1786147200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004271","name":"University of Rome La Sapienza","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004271","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.micpath.2026.108757","type":"journal-article","created":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T15:09:32Z","timestamp":1786201772000},"page":"108757","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Antivirulence strategies targeting adhesion and biofilm formation in uropathogenic E. coli: Recent advances and clinical perspectives-review"],"prefix":"10.1016","volume":"219","author":[{"given":"Amina","family":"Bougouizi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astri Dwyanti","family":"Tagueha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Nencioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Ambrosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2901-265X","authenticated-orcid":false,"given":"Daniela","family":"Scribano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.micpath.2026.108757_bib1","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1186\/s12879-025-10788-8","article-title":"Prevalence, antimicrobial sensitivity patterns and associated factors of urinary tract infection among patients attending nekemte comprehensive specialized hospital, Western Ethiopia, 2024: a cross-sectional study","volume":"25","author":"Diriba","year":"2025","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.micpath.2026.108757_bib2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.annepidem.2025.02.010","article-title":"Epidemiology of urinary tract infection among community-living seniors aged 50 plus: population estimates and risk factors","volume":"104","author":"Foxman","year":"2025","journal-title":"Ann. Epidemiol."},{"key":"10.1016\/j.micpath.2026.108757_bib3","doi-asserted-by":"crossref","first-page":"4702","DOI":"10.1038\/s41598-025-89240-5","article-title":"Epidemiological trends and predictions of urinary tract infections in the global burden of disease study 2021","volume":"15","author":"He","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.micpath.2026.108757_bib4","doi-asserted-by":"crossref","DOI":"10.1177\/1756287219832172","article-title":"An introduction to the epidemiology and burden of urinary tract infections","volume":"11","author":"Medina","year":"2019","journal-title":"Ther. Adv. Urol."},{"key":"10.1016\/j.micpath.2026.108757_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2024.1507505","article-title":"Prevalence and antibiotic resistance profile of UTI-Causing uropathogenic bacteria in diabetics and non-diabetics at the maternity and children hospital in jeddah, Saudi Arabia","volume":"15","author":"Farag","year":"2024","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.micpath.2026.108757_bib6","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/7278070","article-title":"Virulence factors and antimicrobial resistance of uropathogenic Escherichia coli EQ101 UPEC isolated from UTI patient in quetta, Balochistan, Pakistan","volume":"2023","author":"Fatima","year":"2023","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.micpath.2026.108757_bib7","series-title":"Soci\u00e9t\u00e9 Fran\u00e7aise de Microbiologie","article-title":"CASFM\/EUCAST 2019","author":"Vong","year":"2019"},{"key":"10.1016\/j.micpath.2026.108757_bib8","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/s41385-022-00549-0","article-title":"The impact of biological sex on diseases of the urinary tract","volume":"15","author":"Deltourbe","year":"2022","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.micpath.2026.108757_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1100\/2012\/349597","article-title":"Gender and age-dependent etiology of community-acquired urinary tract infections","volume":"2012","author":"Magliano","year":"2012","journal-title":"Sci. World J."},{"key":"10.1016\/j.micpath.2026.108757_bib10","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.3390\/antibiotics10091098","article-title":"Urinary tract infections in elderly patients: a 10-Year study on their epidemiology and antibiotic resistance based on the WHO access, watch, reserve (AWaRe) classification","volume":"10","author":"Gajd\u00e1cs","year":"2021","journal-title":"Antibiotics"},{"key":"10.1016\/j.micpath.2026.108757_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioflm.2024.100212","article-title":"The maturation of native uropathogenic Escherichia coli biofilms seen through a non-interventional lens","volume":"8","author":"Zhang","year":"2024","journal-title":"Biofilm"},{"key":"10.1016\/j.micpath.2026.108757_bib12","doi-asserted-by":"crossref","first-page":"293","DOI":"10.18203\/2349-2902.isj20220315","article-title":"Age and gender based study of urine microscopy in children and adolescents: a retrospective study","volume":"9","author":"Umman","year":"2022","journal-title":"Int. Surg. J"},{"key":"10.1016\/j.micpath.2026.108757_bib13","first-page":"10","article-title":"Adhesins of uropathogenic Escherichia coli (UPEC)","volume":"2","author":"Baby","year":"2016","journal-title":"Int. J. Med. Microbiol. Trop. Dis."},{"key":"10.1016\/j.micpath.2026.108757_bib14","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.21608\/nrmj.2022.251024","article-title":"Uropathogenic Escherichia coli in urinary tract infections: a review on epidemiology, pathogenesis, clinical manifestation, diagnosis, treatments and prevention","volume":"6","author":"Kumar Shrestha","year":"2022","journal-title":"Nov. Res. Microbiol. J."},{"key":"10.1016\/j.micpath.2026.108757_bib15","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.3390\/microorganisms11092169","article-title":"Uropathogenic Escherichia coli (UPEC)-associated urinary tract infections: the molecular basis for challenges to effective treatment","volume":"11","author":"Whelan","year":"2023","journal-title":"Microorganisms"},{"key":"10.1016\/j.micpath.2026.108757_bib16","series-title":"Microbiology of Urinary Tract Infections - Microbial Agents and Predisposing Factors","article-title":"Virulence factors of uropathogenic E. coli","author":"Alam Parvez","year":"2019"},{"key":"10.1016\/j.micpath.2026.108757_bib17","article-title":"Znaczenie uropatogennych szczep\u00f3w escherichia coli (UPEC) w etiopatogenezie zaka\u017ce\u0144 uk\u0142adu moczowego","volume":"55","author":"Chmielewska","year":"2016","journal-title":"Postepy Mikrobiol."},{"key":"10.1016\/j.micpath.2026.108757_bib18","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.3390\/microorganisms10071425","article-title":"Urinary tract infections caused by uropathogenic Escherichia coli strains\u2014new strategies for an old pathogen","volume":"10","author":"Zagaglia","year":"2022","journal-title":"Microorganisms"},{"key":"10.1016\/j.micpath.2026.108757_bib19","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.UTI-0018-2013","article-title":"Structure, function, and assembly of adhesive organelles by uropathogenic bacteria","volume":"3","author":"Chahales","year":"2015","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.micpath.2026.108757_bib20","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2217\/17460913.1.1.75","article-title":"Sticky fibers and uropathogenesis: bacterial adhesins in the urinary tract","volume":"1","author":"Wright","year":"2006","journal-title":"Future Microbiol."},{"key":"10.1016\/j.micpath.2026.108757_bib21","doi-asserted-by":"crossref","DOI":"10.4103\/jrms.jrms_637_22","article-title":"Correlation of biofilm formation, virulence factors, and phylogenetic groups among Escherichia coli strains causing urinary tract infection: a global systematic review and meta-analysis","volume":"28","author":"Mirzahosseini","year":"2023","journal-title":"J. Res. Med. Sci."},{"key":"10.1016\/j.micpath.2026.108757_bib22","author":"Qahtan"},{"key":"10.1016\/j.micpath.2026.108757_bib23","doi-asserted-by":"crossref","first-page":"761","DOI":"10.3855\/jidc.18566","article-title":"Evaluation of adhesin genes and risk factors associated with urinary tract infections by drug-resistant uropathogenic Escherichia coli in north of Iran","volume":"18","author":"Sheikhi","year":"2024","journal-title":"J. Infect. Dev. Ctries."},{"key":"10.1016\/j.micpath.2026.108757_bib24","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3390\/antibiotics13020154","article-title":"Novel antimicrobial approaches to combat bacterial biofilms associated with urinary tract infections","volume":"13","author":"Mancuso","year":"2024","journal-title":"Antibiotics"},{"key":"10.1016\/j.micpath.2026.108757_bib25","first-page":"3","article-title":"Biofilm-producing potential of urinary pathogens isolated from chronic and recurrent urinary tract infections and impact of biofilm on gentamicin and colistin in vitro efficacy","volume":"69","author":"Va\u0161kov\u00e1","year":"2020","journal-title":"Epidemiol. Mikrobiol. Imunol."},{"key":"10.1016\/j.micpath.2026.108757_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2022\/9520362","article-title":"Genetic diversity, carbapenem resistance genes, and biofilm formation in UPEC isolated from patients with catheter-associated urinary tract infection in north of Iran","volume":"2022","author":"Nasrollahian","year":"2022","journal-title":"Int. J. Clin. Pract."},{"key":"10.1016\/j.micpath.2026.108757_bib27","doi-asserted-by":"crossref","first-page":"383","DOI":"10.3855\/jidc.18263","article-title":"Prevalence and characterization of carbapenem-resistant Enterobacterales among inpatients and outpatients in Skikda, Algeria","volume":"18","author":"Bougouizi","year":"2024","journal-title":"J. Infect. Dev. Ctries."},{"key":"10.1016\/j.micpath.2026.108757_bib28","doi-asserted-by":"crossref","DOI":"10.1155\/cjid\/9021465","article-title":"Third\u2010generation cephalosporin\u2010resistant uropathogenic Escherichia coli from community\u2010 and hospital\u2010acquired infections show high level of antibiotic resistance and specific virulence traits","volume":"2025","author":"Bougouizi","year":"2025","journal-title":"Can. J. Infect. Dis. Med. Microbiol."},{"key":"10.1016\/j.micpath.2026.108757_bib29","doi-asserted-by":"crossref","DOI":"10.47191\/ijcsrr\/V7-i10-64","article-title":"Extended spectrum \u03b2-Lactamase: tackling antibiotic resistance and overcoming treatment challenges","volume":"7","author":"Muppa","year":"2024","journal-title":"Ijcsrr"},{"key":"10.1016\/j.micpath.2026.108757_bib30","series-title":"Virulence Genes, Phylogenetic, and Antimicrobial Resistance of Escherichia coli Isolated from Urinary Tract Infection in Hospital Inpatients and Outpatients","author":"Derakhshan","year":"2022"},{"key":"10.1016\/j.micpath.2026.108757_bib31","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1093\/jac\/dkx525","article-title":"Comparison of risk factors for, and prevalence of, antibiotic resistance in contaminating and pathogenic urinary Escherichia coli in children in primary care: prospective cohort study","volume":"73","author":"Bryce","year":"2018","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.micpath.2026.108757_bib32","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1093\/cid\/civ696","article-title":"Asymptomatic bacteriuria treatment is associated with a higher prevalence of antibiotic resistant strains in women with urinary tract infections","volume":"61","author":"Cai","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.micpath.2026.108757_bib33","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1093\/cid\/cit284","article-title":"Urinary tract infections: current and emerging management strategies","volume":"57","author":"Barber","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.micpath.2026.108757_bib34","doi-asserted-by":"crossref","DOI":"10.1128\/aac.01481-23","article-title":"High efficacy treatment of murine Pseudomonas aeruginosa catheter-associated urinary tract infections using the c-di-GMP modulating anti-biofilm compound disperazol in combination with ciprofloxacin","author":"Hultqvist","year":"2024","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2026.108757_bib35","doi-asserted-by":"crossref","first-page":"437s","DOI":"10.1093\/ajcn\/73.2.437s","article-title":"Probiotic agents to protect the urogenital tract against infection","volume":"73","author":"Reid","year":"2001","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.micpath.2026.108757_bib36","doi-asserted-by":"crossref","first-page":"397","DOI":"10.3390\/antibiotics9070397","article-title":"FimH and anti-adhesive therapeutics: a disarming strategy against uropathogens","volume":"9","author":"Sarshar","year":"2020","journal-title":"Antibiotics"},{"key":"10.1016\/j.micpath.2026.108757_bib37","doi-asserted-by":"crossref","first-page":"316","DOI":"10.3390\/molecules25020316","article-title":"d-Mannose treatment neither affects uropathogenic Escherichia coli properties nor induces stable FimH modifications","volume":"25","author":"Scribano","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.micpath.2026.108757_bib38","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1186\/s12879-020-05186-1","article-title":"Biofilm formation, antimicrobial susceptibility and virulence genes of uropathogenic Escherichia coli isolated from clinical isolates in Uganda","volume":"20","author":"Katongole","year":"2020","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.micpath.2026.108757_bib39","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.29404","article-title":"Virulence genotyping and multidrug resistance pattern of Escherichia coli isolated from community-acquired and hospital-acquired urinary tract infections","author":"Radera","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.micpath.2026.108757_bib40","doi-asserted-by":"crossref","DOI":"10.22207\/JPAM.19.3.43","article-title":"Characterization of virulence genetic profile and potential effect of nanoparticles against multidrug-resistant uropathogenic E. coli at menuofia university hospitals","author":"Mostafa","year":"2025","journal-title":"J. Pure Appl. Microbiol."},{"key":"10.1016\/j.micpath.2026.108757_bib41","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jhin.2021.08.017","article-title":"Biofilm formation by uropathogenic escherichia coli: a complicating factor for treatment and recurrence of urinary tract infections","volume":"117","author":"Naziri","year":"2021","journal-title":"J. Hosp. Infect."},{"key":"10.1016\/j.micpath.2026.108757_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2021\/8869275","article-title":"Biofilm-producing bacteria and risk factors (gender and duration of catheterization) characterized as catheter-associated biofilm formation","volume":"2021","author":"Gunardi","year":"2021","journal-title":"Int. J. Microbiol."},{"key":"10.1016\/j.micpath.2026.108757_bib43","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/JU.0000000000000492","article-title":"The natural history and composition of urinary catheter biofilms: early uropathogen colonization with intraluminal and distal predominance","volume":"203","author":"Werneburg","year":"2020","journal-title":"J. Urol."},{"key":"10.1016\/j.micpath.2026.108757_bib44","first-page":"17","article-title":"Detection of biofilm among uropathogenic Escherichia coli and its correlation with antibiotic resistance pattern","volume":"11","author":"Karigoudar","year":"2019","journal-title":"J. Lab Phy."},{"key":"10.1016\/j.micpath.2026.108757_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2025.1570422","article-title":"Comparative evaluation of biofilm-forming capacity in uropathogenic and commensal Escherichia coli","volume":"15","author":"Mahale","year":"2025","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.micpath.2026.108757_bib46","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1186\/s12879-025-10635-w","article-title":"Analysis of phylogroups, biofilm formation, virulence factors, antibiotic resistance and molecular typing of uropathogenic Escherichia coli strains isolated from patients with recurrent and non-recurrent urinary tract infections","volume":"25","author":"Mahshouri","year":"2025","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.micpath.2026.108757_bib47","doi-asserted-by":"crossref","first-page":"691","DOI":"10.18280\/ijdne.200401","article-title":"Effect of ciprofloxacin and trimethoprim\/sulfamethoxazole on biofilm formation of multi-drug resistant uropathogenic Escherichia coli","volume":"20","author":"Al-Zaidi","year":"2025","journal-title":"IJDNE"},{"key":"10.1016\/j.micpath.2026.108757_bib48","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1071\/MA23030","article-title":"Uropathogenic Escherichia coli biofilms","volume":"44","author":"Nhu","year":"2023","journal-title":"Microbiology Australia"},{"key":"10.1016\/j.micpath.2026.108757_bib49","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1093\/jac\/dkad201","article-title":"Uropathogenic Escherichia coli population structure and antimicrobial susceptibility in Norfolk, UK","volume":"78","author":"Carter","year":"2023","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.micpath.2026.108757_bib50","first-page":"1753","article-title":"[using plant extracts and their active ingredients to inhibit bacterial biofilms]","volume":"38","author":"Cheng","year":"2022","journal-title":"Sheng Wu Gong Cheng Xue Bao"},{"key":"10.1016\/j.micpath.2026.108757_bib51","doi-asserted-by":"crossref","first-page":"528","DOI":"10.4161\/viru.2.6.18189","article-title":"Characteristics of Escherichia coli causing persistence or relapse of urinary tract infections: phylogenetic groups, virulence factors and biofilm formation","volume":"2","author":"Ejrn\u00e6s","year":"2011","journal-title":"Virulence"},{"key":"10.1016\/j.micpath.2026.108757_bib52","article-title":"Bacterial outer membrane vesicles: from physics to clinical","volume":"4","author":"Zhou","year":"2025","journal-title":"MedComm \u2013 Biomater. Appl."},{"key":"10.1016\/j.micpath.2026.108757_bib53","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.161461","article-title":"E. coli catheter-associated urinary tract infections are associated with distinctive virulence and biofilm gene determinants","volume":"8","author":"Zou","year":"2023","journal-title":"JCI Insight"},{"key":"10.1016\/j.micpath.2026.108757_bib54","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.ajic.2018.01.015","article-title":"The attributable cost of catheter-associated urinary tract infections in the United States: a systematic review","volume":"46","author":"Hollenbeak","year":"2018","journal-title":"Am. J. Infect. Control"},{"key":"10.1016\/j.micpath.2026.108757_bib55","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1017\/ice.2024.26","article-title":"Catheter-associated urinary tract infections (CAUTIs) and non-CAUTI hospital-onset urinary tract infections: relative burden, cost, outcomes and related hospital-onset bacteremia and fungemia infections","volume":"45","author":"Kelly","year":"2024","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"10.1016\/j.micpath.2026.108757_bib56","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41579-020-0324-0","article-title":"Urinary tract infections: microbial pathogenesis, host-pathogen interactions and new treatment strategies","volume":"18","author":"Klein","year":"2020","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.micpath.2026.108757_bib57","series-title":"Molecular Medical Microbiology","first-page":"359","article-title":"Bacterial adhesion","author":"Mendoza-Barber\u00e1","year":"2024"},{"key":"10.1016\/j.micpath.2026.108757_bib58","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1099\/mic.0.2006\/004648-0","article-title":"The role of F9 fimbriae of uropathogenic Escherichia coli in biofilm formation","volume":"153","author":"Ulett","year":"2007","journal-title":"Microbiology"},{"key":"10.1016\/j.micpath.2026.108757_bib59","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.03664-20","article-title":"Discovery of bacterial fimbria\u2013glycan interactions using whole-cell recombinant Escherichia coli expression","volume":"12","author":"Day","year":"2021","journal-title":"mBio"},{"key":"10.1016\/j.micpath.2026.108757_bib60","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/imm.13330","article-title":"The glycobiology of uropathogenic E. coli infection: the sweet and bitter role of sugars in urinary tract immunity","volume":"164","author":"Lupo","year":"2021","journal-title":"Immunology"},{"key":"10.1016\/j.micpath.2026.108757_bib61","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.3389\/fmicb.2017.01566","article-title":"UroPathogenic Escherichia coli (UPEC) infections: virulence factors, bladder responses, antibiotic, and non-antibiotic antimicrobial strategies","volume":"8","author":"Terlizzi","year":"2017","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.micpath.2026.108757_bib62","doi-asserted-by":"crossref","first-page":"43","DOI":"10.11648\/j.scidev.20250603.11","article-title":"Comprehensive review of uropathogenic Escherichia coli ; virulence factors and their role in urinary tract infection","volume":"6","author":"Mitiku","year":"2025","journal-title":"SciDev"},{"key":"10.1016\/j.micpath.2026.108757_bib63","doi-asserted-by":"crossref","first-page":"60","DOI":"10.14777\/uti.2448022011","article-title":"Mechanistic insights into persistent bacterial cystitis as a basis for vaccine development: a narrative review","volume":"19","author":"Serrano-Arevalo","year":"2024","journal-title":"Urogenit. Tract. Infect."},{"key":"10.1016\/j.micpath.2026.108757_bib64","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0268243","article-title":"The role of uropathogenic Escherichia coli adhesive molecules in inflammatory response- comparative study on immunocompetent hosts and kidney recipients","volume":"17","author":"Wojciuk","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.micpath.2026.108757_bib65","article-title":"Uropathogenic Escherichia coli causes significant urothelial damage in an ex vivo porcine bladder model, with no protective effect observed from cranberry or d-mannose","volume":"82","author":"Konesan","year":"2024","journal-title":"Pathogen. Dis."},{"key":"10.1016\/j.micpath.2026.108757_bib66","series-title":"Molecular Medical Microbiology","first-page":"409","article-title":"Adhesion and colonization","author":"Abraham","year":"2015"},{"key":"10.1016\/j.micpath.2026.108757_bib67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/681473","article-title":"Role of uropathogenic Escherichia coli virulence factors in development of urinary tract infection and kidney damage","volume":"2012","author":"Bien","year":"2012","journal-title":"Int. J. Nephrol."},{"key":"10.1016\/j.micpath.2026.108757_bib68","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.jmb.2009.06.077","article-title":"Uropathogenic E. coli adhesin-induced host cell receptor conformational changes: implications in transmembrane signaling transduction","volume":"392","author":"Wang","year":"2009","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.micpath.2026.108757_bib69","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1517\/13543776.2016.1131266","article-title":"Mannose-derived FimH antagonists: a promising anti-virulence therapeutic strategy for urinary tract infections and Crohn's disease","volume":"26","author":"Mydock-McGrane","year":"2016","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.micpath.2026.108757_bib70","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1080\/17460441.2017.1331216","article-title":"Rational design strategies for FimH antagonists: new drugs on the horizon for urinary tract infection and Crohn's disease","volume":"12","author":"Mydock-McGrane","year":"2017","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.micpath.2026.108757_bib71","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1001298","article-title":"Uropathogenic Escherichia coli P and type 1 fimbriae act in synergy in a living host to facilitate renal colonization leading to nephron obstruction","volume":"7","author":"Melican","year":"2011","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.micpath.2026.108757_bib72","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.3390\/microorganisms11122858","article-title":"Biofilm formation by Escherichia coli isolated from urinary tract infections from Aguascalientes, Mexico","volume":"11","author":"Ram\u00edrez Castillo","year":"2023","journal-title":"Microorganisms"},{"key":"10.1016\/j.micpath.2026.108757_bib73","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1107\/S2052252516016675","article-title":"Mutation of Tyr137 of the universal Escherichia coli fimbrial adhesin FimH relaxes the tyrosine gate prior to mannose binding","volume":"4","author":"Rabbani","year":"2017","journal-title":"IUCrJ"},{"key":"10.1016\/j.micpath.2026.108757_bib74","doi-asserted-by":"crossref","first-page":"15530","DOI":"10.1073\/pnas.1315203110","article-title":"Positively selected FimH residues enhance virulence during urinary tract infection by altering FimH conformation","volume":"110","author":"Schwartz","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.micpath.2026.108757_bib75","first-page":"829","article-title":"Molecular analysis of fimA operon genes among UPEC local isolates in Baghdad city","volume":"76","author":"Abdul Raheem Hasan","year":"2021","journal-title":"Arch. Razi. Inst."},{"key":"10.1016\/j.micpath.2026.108757_bib76","series-title":"Detection of Pap, Sfa, Afa, Foc, and Fim Adhesin-Encoding Operons in Uropathogenic Escherichia coli Isolates Collected from Patients with Urinary Tract Infection","author":"Rahdar","year":"2015"},{"key":"10.1016\/j.micpath.2026.108757_bib77","series-title":"Advances in Microbial Physiology","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-2911(01)45001-6","article-title":"The regulation of pap and type 1 fimbriation in escherichia cola","author":"Blomfield","year":"2001"},{"key":"10.1016\/j.micpath.2026.108757_bib78","first-page":"3315","article-title":"Increased levels of (p)ppGpp correlate with virulence and biofilm formation, but not with growth","volume":"24","author":"Karczewska","year":"2023","journal-title":"Strains Uropathogen. Escherichia coli, IJMS"},{"key":"10.1016\/j.micpath.2026.108757_bib79","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1128\/CMR.17.3.581-611.2004","article-title":"Phase and antigenic variation in bacteria","volume":"17","author":"van der Woude","year":"2004","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.micpath.2026.108757_bib80","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00820-15","article-title":"Human urine decreases function and expression of type 1 pili in uropathogenic Escherichia coli","volume":"6","author":"Greene","year":"2015","journal-title":"mBio"},{"key":"10.1016\/j.micpath.2026.108757_bib81","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1093\/glycob\/cwz059","article-title":"PapG subtype-specific binding characteristics of Escherichia coli towards globo-series glycosphingolipids of human kidney and bladder uroepithelial cells","volume":"29","author":"Legros","year":"2019","journal-title":"Glycobiology"},{"key":"10.1016\/j.micpath.2026.108757_bib82","doi-asserted-by":"crossref","first-page":"5898","DOI":"10.1073\/pnas.84.16.5898","article-title":"The PapG protein is the alpha-D-galactopyranosyl-(1----4)-beta-D-galactopyranose-binding adhesin of uropathogenic Escherichia coli","volume":"84","author":"Lund","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.micpath.2026.108757_bib83","doi-asserted-by":"crossref","first-page":"5968","DOI":"10.1038\/s41467-020-19714-9","article-title":"Horizontally acquired papGII-containing pathogenicity islands underlie the emergence of invasive uropathogenic Escherichia coli lineages","volume":"11","author":"Biggel","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.micpath.2026.108757_bib84","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/S1097-2765(03)00383-6","article-title":"The mechanism by which DNA adenine methylase and PapI activate the pap epigenetic switch","volume":"12","author":"Hernday","year":"2003","journal-title":"Mol. Cell"},{"key":"10.1016\/j.micpath.2026.108757_bib85","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1365-2958.1993.tb01145.x","article-title":"Regulation of pyelonephritis-associated pili phase-variation in escherichia coli: binding of the PapI and the lrp regulatory proteins is controlled by DNA methylation","volume":"7","author":"Nou","year":"1993","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.micpath.2026.108757_bib86","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1177\/08959374970110011701","article-title":"Bacterial attachment to uro-epithelial cells: mechanisms and consequences","volume":"11","author":"Connell","year":"1997","journal-title":"Adv. Dent. Res."},{"key":"10.1016\/j.micpath.2026.108757_bib87","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s12929-022-00848-5","article-title":"Distribution of papG alleles among uropathogenic Escherichia coli from reproductive age women","volume":"29","author":"Kudinha","year":"2022","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.micpath.2026.108757_bib88","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1757-4749-1-22","article-title":"Adhesive threads of extraintestinal pathogenic Escherichia coli","volume":"1","author":"Ant\u00e3o","year":"2009","journal-title":"Gut Pathog."},{"key":"10.1016\/j.micpath.2026.108757_bib89","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1099\/mic.0.039610-0","article-title":"Mat fimbriae promote biofilm formation by meningitis-associated Escherichia coli","volume":"156","author":"Lehti","year":"2010","journal-title":"Microbiology"},{"key":"10.1016\/j.micpath.2026.108757_bib90","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1172\/JCI113395","article-title":"Binding sites in the rat brain for Escherichia coli S fimbriae associated with neonatal meningitis","volume":"81","author":"Parkkinen","year":"1988","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.micpath.2026.108757_bib91","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1128\/iai.65.7.2852-2860.1997","article-title":"Identification and characterization of S fimbria-binding sialoglycoproteins on brain microvascular endothelial cells","volume":"65","author":"Prasadarao","year":"1997","journal-title":"Infect. Immun."},{"key":"10.1016\/j.micpath.2026.108757_bib92","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.958653","article-title":"Microbial lectome versus host glycolipidome: how pathogens exploit glycosphingolipids to invade, dupe or kill","volume":"13","author":"Bereznicka","year":"2022","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.micpath.2026.108757_bib93","doi-asserted-by":"crossref","first-page":"2","DOI":"10.34172\/ajcmi.2019.02","article-title":"Evaluation of biofilm formation and frequency of genes encoding curli fiber, colanic acid capsule and F1c fimberia among uropathogenic Escherichia coli isolates with strong cell surface hydrophobicity","volume":"6","author":"Honarmand Jahromy","year":"2019","journal-title":"Avicenna. J. Clin. Microbiol. Infect."},{"key":"10.1016\/j.micpath.2026.108757_bib94","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3390\/ijms24010161","article-title":"Diversity in genetic regulation of bacterial fimbriae assembled by the chaperone usher pathway","volume":"24","author":"Gahlot","year":"2022","journal-title":"IJMS"},{"key":"10.1016\/j.micpath.2026.108757_bib95","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.chom.2016.08.013","article-title":"Inflammation-induced adhesin-receptor interaction provides a fitness advantage to uropathogenic E. coli during chronic infection","volume":"20","author":"Conover","year":"2016","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.micpath.2026.108757_bib96","doi-asserted-by":"crossref","first-page":"3668","DOI":"10.1021\/acs.jmedchem.3c02128","article-title":"Discovery of orally bioavailable FmlH lectin antagonists as treatment for urinary tract infections","volume":"67","author":"Maddirala","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.micpath.2026.108757_bib97","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1021\/acs.jmedchem.8b01561","article-title":"Biphenyl gal and GalNAc FmlH lectin antagonists of uropathogenic E. coli (UPEC): optimization through iterative rational drug design","volume":"62","author":"Maddirala","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.micpath.2026.108757_bib98","doi-asserted-by":"crossref","first-page":"3.4.20","DOI":"10.1128\/microbiolspec.UTI-0015-2012","article-title":"Virulence and fitness determinants of uropathogenic Escherichia coli","volume":"3","author":"Subashchandrabose","year":"2015","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.micpath.2026.108757_bib99","article-title":"OxyR is required for oxidative stress resistance of the entomopathogenic bacterium Xenorhabdus nematophila and has a minor role during the bacterial interaction with its hosts","volume":"170","author":"Bientz","year":"2024","journal-title":"Microbiology (Read.)"},{"key":"10.1016\/j.micpath.2026.108757_bib100","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13073-023-01243-x","article-title":"Bacterial genome-wide association study substantiates papGII of Escherichia coli as a major risk factor for urosepsis","volume":"15","author":"Cu\u00e9nod","year":"2023","journal-title":"Genome Med."},{"key":"10.1016\/j.micpath.2026.108757_bib101","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.3389\/fmicb.2019.02063","article-title":"Curli of uropathogenic Escherichia coli enhance urinary tract colonization as a fitness factor","volume":"10","author":"Luna-Pineda","year":"2019","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.micpath.2026.108757_bib102","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01462-18","article-title":"Discovery of new genes involved in curli production by a uropathogenic Escherichia coli strain from the highly virulent O45:K1:H7 lineage","volume":"9","author":"Nhu","year":"2018","journal-title":"mBio"},{"key":"10.1016\/j.micpath.2026.108757_bib103","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1128\/CMR.18.2.264-292.2005","article-title":"Pathogenesis of Afa\/Dr diffusely adhering Escherichia coli","volume":"18","author":"Servin","year":"2005","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.micpath.2026.108757_bib104","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1128\/JB.185.7.2203-2209.2003","article-title":"Phase variation of Ag43 is independent of the oxidation state of OxyR","volume":"185","author":"Wallecha","year":"2003","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.micpath.2026.108757_bib105","doi-asserted-by":"crossref","first-page":"lxag013","DOI":"10.1093\/jambio\/lxag013","article-title":"The CpxA\/R system mediates the regulation of TolC on biofilm formation by extraintestinal pathogenic Escherichia coli in response to medium osmolarity","volume":"137","author":"Bao","year":"2026","journal-title":"J. Appl. Microbiol."},{"key":"10.1016\/j.micpath.2026.108757_bib106","doi-asserted-by":"crossref","DOI":"10.1128\/jb.00281-25","article-title":"Effects of multiple cell regulators on curli gene expression in Escherichia coli","volume":"207","author":"Ratnikava","year":"2025","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.micpath.2026.108757_bib107","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00222-18","article-title":"TosR-Mediated regulation of adhesins and biofilm formation in uropathogenic Escherichia coli","volume":"3","author":"Luterbach","year":"2018","journal-title":"mSphere"},{"key":"10.1016\/j.micpath.2026.108757_bib108","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1128\/IAI.05713-11","article-title":"The repeat-in-toxin family member TosA mediates adherence of uropathogenic Escherichia coli and survival during bacteremia","volume":"80","author":"Vigil","year":"2012","journal-title":"Infect. Immun."},{"key":"10.1016\/j.micpath.2026.108757_bib109","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3390\/life13010148","article-title":"Biofilm lifestyle in recurrent urinary tract infections","volume":"13","author":"Lila","year":"2023","journal-title":"Life"},{"key":"10.1016\/j.micpath.2026.108757_bib110","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/CU9.0000000000000308","article-title":"The role of uropathogenic Escherichia coli biofilms in antibiotic-resistant urinary tract infections: nanoparticle-based, phage therapy, and quorum-sensing inhibitor approaches","volume":"20","author":"Eskandar","year":"2026","journal-title":"Curr. Urol."},{"key":"10.1016\/j.micpath.2026.108757_bib111","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1071\/MA23030","article-title":"Uropathogenic Escherichia coli biofilms","volume":"44","author":"Nhu","year":"2023","journal-title":"Microbiol. Aust."},{"key":"10.1016\/j.micpath.2026.108757_bib112","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3906\/sag-1707-3","article-title":"Biofilm formation in uropathogenic Escherichia coli: association with adhesion factor genes","volume":"48","author":"Zamani","year":"2018","journal-title":"Turk. J. Med. Sci."},{"key":"10.1016\/j.micpath.2026.108757_bib113","doi-asserted-by":"crossref","first-page":"9760","DOI":"10.3390\/ijms26199760","volume":"26","author":"Krawczyk","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.micpath.2026.108757_bib114","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1073\/pnas.1311592111","article-title":"The antigen 43 structure reveals a molecular Velcro-like mechanism of autotransporter-mediated bacterial clumping","volume":"111","author":"Heras","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.micpath.2026.108757_bib115","doi-asserted-by":"crossref","first-page":"5769","DOI":"10.1128\/JB.01264-12","article-title":"Functional heterogeneity of the UpaH autotransporter protein from uropathogenic Escherichia coli","volume":"194","author":"Allsopp","year":"2012","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.micpath.2026.108757_bib116","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s41522-022-00284-1","article-title":"Variation of Antigen 43 self-association modulates bacterial compacting within aggregates and biofilms","volume":"8","author":"Vo","year":"2022","journal-title":"npj Biofilms Microbiomes"},{"key":"10.1016\/j.micpath.2026.108757_bib117","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ijmm.2004.11.004","article-title":"Hierarchical gene regulators adapt Salmonella enterica to its host milieus","volume":"294","author":"Rhen","year":"2005","journal-title":"Int. J. Med. Microbiol."},{"key":"10.1016\/j.micpath.2026.108757_bib118","doi-asserted-by":"crossref","first-page":"33","DOI":"10.18869\/acadpub.mlj.9.5.33","article-title":"The ability of cellulose polysaccharide and curli pili production in uropathogenic Escherichia coli and its association with biofilm formation intensity","volume":"9","author":"Khozein","year":"2015","journal-title":"Mljgoums"},{"key":"10.1016\/j.micpath.2026.108757_bib119","doi-asserted-by":"crossref","first-page":"13","DOI":"10.7242\/2658-705X\/2022.1.2","article-title":"Biofilm formation of Escherichia coli title as a trigger of catheter-associated urinary tract infections","volume":"15","author":"Kuznecova","year":"2022","journal-title":"Perm Sci. Cent. J."},{"key":"10.1016\/j.micpath.2026.108757_bib120","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.tim.2020.03.016","article-title":"Biofilm matrixome: extracellular components in structured microbial communities","volume":"28","author":"Karygianni","year":"2020","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.micpath.2026.108757_bib121","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.chom.2019.06.002","article-title":"Surviving as a community: antibiotic tolerance and persistence in bacterial biofilms","volume":"26","author":"Yan","year":"2019","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.micpath.2026.108757_bib122","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.03304-23","article-title":"Outer membrane vesicles and the outer membrane protein OmpU govern Vibrio cholerae biofilm matrix assembly","volume":"15","author":"Potapova","year":"2024","journal-title":"mBio"},{"key":"10.1016\/j.micpath.2026.108757_bib123","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s10123-022-00235-y","article-title":"Adaptive strategies of uropathogenic Escherichia coli CFT073: from growth in lab media to virulence during host cell adhesion","volume":"25","author":"Sarshar","year":"2022","journal-title":"Int. Microbiol."},{"key":"10.1016\/j.micpath.2026.108757_bib124","doi-asserted-by":"crossref","first-page":"328","DOI":"10.3390\/antibiotics12020328","article-title":"Horizontal gene transfer of antibiotic resistance genes in biofilms","volume":"12","author":"Michaelis","year":"2023","journal-title":"Antibiotics"},{"key":"10.1016\/j.micpath.2026.108757_bib125","doi-asserted-by":"crossref","first-page":"4147","DOI":"10.1128\/JB.00122-08","article-title":"UpaG, a new member of the trimeric autotransporter family of Escherichia coli","volume":"190","author":"Valle","year":"2008","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.micpath.2026.108757_bib126","doi-asserted-by":"crossref","first-page":"9760","DOI":"10.3390\/ijms26199760","article-title":"The role of Escherichia coli autotransporters in urinary tract infections and urosepsis","volume":"26","author":"Krawczyk","year":"2025","journal-title":"IJMS"},{"key":"10.1016\/j.micpath.2026.108757_bib127","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ijmm.2013.10.006","volume":"304","author":"Zude","year":"2014","journal-title":"Int. J. Med. Microbiol."},{"key":"10.1016\/j.micpath.2026.108757_bib128","doi-asserted-by":"crossref","first-page":"5546","DOI":"10.24996\/ijs.2024.65.10.19","article-title":"Antibiotic resistance, biofilm formation, and identification of FimH and FimA adhesion genes in uropathogenic Escherichia Coli (UPEC) isolated from patients in Baghdad province","author":"Hamid","year":"2024","journal-title":"Iraqi J. Sci."},{"key":"10.1016\/j.micpath.2026.108757_bib129","doi-asserted-by":"crossref","first-page":"835","DOI":"10.3390\/pathogens9100835","article-title":"Enterococcus faecalis polymicrobial interactions facilitate biofilm formation, antibiotic recalcitrance, and persistent colonization of the catheterized urinary tract","volume":"9","author":"Gaston","year":"2020","journal-title":"Pathogens"},{"key":"10.1016\/j.micpath.2026.108757_bib130","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1111\/j.1469-0691.2006.01543.x","article-title":"Implication of biofilm formation in the persistence of urinary tract infection caused by uropathogenic Escherichia coli","volume":"12","author":"Soto","year":"2006","journal-title":"Clin. Microbiol. Infection"},{"key":"10.1016\/j.micpath.2026.108757_bib131","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3390\/diseases8020017","article-title":"Association between biofilm-production and antibiotic resistance in uropathogenic Escherichia coli (UPEC): an in vitro study","volume":"8","author":"Behzadi","year":"2020","journal-title":"Diseases"},{"key":"10.1016\/j.micpath.2026.108757_bib132","doi-asserted-by":"crossref","first-page":"1","DOI":"10.47352\/jmans.2774-3047.222","article-title":"Detection of csg and lux genes in biofilm-forming uropathogenic Escherichia coli associated with urinary tract infections","volume":"5","author":"Purbowati","year":"2024","journal-title":"J. Multidiscip. Appl. Nat. Sci."},{"key":"10.1016\/j.micpath.2026.108757_bib133","doi-asserted-by":"crossref","first-page":"494","DOI":"10.4161\/rna.28867","article-title":"Small RNAs in the control of RpoS, CsgD, and biofilm architecture of Escherichia coli","volume":"11","author":"Mika","year":"2014","journal-title":"RNA Biol."},{"key":"10.1016\/j.micpath.2026.108757_bib134","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.18203\/2394-6040.ijcmph20222344","article-title":"Overview of the causes and types of recurrent cystitis","volume":"9","author":"Alaryan","year":"2022","journal-title":"Int. J. Commun. Med. Public Health"},{"key":"10.1016\/j.micpath.2026.108757_bib135","first-page":"409","article-title":"[type 1 fimbriae, P fimbriae and X adhesins in escherichia strains causing pyelonephritis, cystitis and recurrent urinary infections]","volume":"92","author":"Andreu","year":"1989","journal-title":"Med. Clin."},{"key":"10.1016\/j.micpath.2026.108757_bib136","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.1128\/iai.65.10.4309-4318.1997","article-title":"Molecular cloning and characterization of Dr-II, a nonfimbrial adhesin-I-like adhesin isolated from gestational pyelonephritis-associated Escherichia coli that binds to decay-accelerating factor","volume":"65","author":"Pham","year":"1997","journal-title":"Infect. Immun."},{"key":"10.1016\/j.micpath.2026.108757_bib137","doi-asserted-by":"crossref","first-page":"7597","DOI":"10.1128\/IAI.73.11.7597-7601.2005","article-title":"Dra\/AfaE adhesin of uropathogenic Dr\/Afa sup+\/sup Escherichia coli mediates mortality in pregnant rats","volume":"73","author":"Wroblewska-Seniuk","year":"2005","journal-title":"Infect. Immun."},{"key":"10.1016\/j.micpath.2026.108757_bib138","doi-asserted-by":"crossref","first-page":"149","DOI":"10.21608\/ajps.2021.153566","article-title":"Genotypic detection of the virulence factors of uropathogenic ESCHERICHIA coli (UPEC) strains isolated from pregnant females and their correlation with antibiotic resistance pattern","volume":"63","author":"Ahmed","year":"2021","journal-title":"Al-Azhar J. Pharm. Sci."},{"key":"10.1016\/j.micpath.2026.108757_bib139","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3390\/diseases13020059","article-title":"Understanding the burden and management of urinary tract infections in women","volume":"13","author":"Baimakhanova","year":"2025","journal-title":"Diseases"},{"key":"10.1016\/j.micpath.2026.108757_bib140","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.1128\/JCM.01647-12","article-title":"Uropathogenic Escherichia coli isolates from pregnant women in different countries","volume":"50","author":"Ramos","year":"2012","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.micpath.2026.108757_bib141","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2147\/IDR.S226215","article-title":"Virulence and resistance determinants of uropathogenic Escherichia coli strains isolated from pregnant and non-pregnant women from two states in Mexico","volume":"13","author":"Ballesteros-Monrreal","year":"2020","journal-title":"Infect. Drug Resist."},{"key":"10.1016\/j.micpath.2026.108757_bib142","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.682626","article-title":"Estradiol alters the virulence traits of uropathogenic Escherichia coli","volume":"12","author":"Engels\u00f6y","year":"2021","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.micpath.2026.108757_bib143","doi-asserted-by":"crossref","DOI":"10.1016\/j.imbio.2020.152020","article-title":"Estrogen receptors in human bladder cells regulate innate cytokine responses to differentially modulate uropathogenic E. coli colonization","volume":"226","author":"Sen","year":"2021","journal-title":"Immunobiology"},{"key":"10.1016\/j.micpath.2026.108757_bib144","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1556683","article-title":"Estrogen and bacterial infection","volume":"16","author":"Hong","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.micpath.2026.108757_bib145","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jmii.2021.04.001","article-title":"Escherichia coli urinary tract infections: host age-related differences in bacterial virulence factors and antimicrobial susceptibility","volume":"55","author":"Lin","year":"2022","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"10.1016\/j.micpath.2026.108757_bib146","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1186\/s12866-025-04506-2","article-title":"Comparative analysis of biofilm detection methods and antibiotic resistance in catheter-associated uropathogens: a cross-sectional study from Syria","volume":"25","author":"Khaddam","year":"2025","journal-title":"BMC Microbiol."},{"key":"10.1016\/j.micpath.2026.108757_bib147","doi-asserted-by":"crossref","DOI":"10.1128\/msphere.00004-22","article-title":"Glycosuria alters uropathogenic Escherichia coli global gene expression and virulence","volume":"7","author":"Islam","year":"2022","journal-title":"mSphere"},{"key":"10.1016\/j.micpath.2026.108757_bib148","series-title":"Increased Bacterial Adherence and Decreased Bacterial Clearance in Urinary Tract Infections with Diabetes Mellitus","author":"Ozer","year":"2013"},{"key":"10.1016\/j.micpath.2026.108757_bib149","doi-asserted-by":"crossref","first-page":"577","DOI":"10.22207\/JPAM.11.1.75","article-title":"Enhanced adhesion and cell damage by Escherichia coli harboring hly, papC and cnf-1genes to the uroepithelium in diabetic mouse bladder model","volume":"11","author":"Anandkumar","year":"2017","journal-title":"J. Pure Appl. Microbiol."},{"key":"10.1016\/j.micpath.2026.108757_bib150","doi-asserted-by":"crossref","first-page":"931","DOI":"10.13005\/bbra\/2117","article-title":"Distribution of virulence factors and antimicrobial resistance properties of uropathogenic Escherichia coli isolated from diabetic and healthy males suffered from urinary tract infections","volume":"13","author":"Rezaee","year":"2016","journal-title":"Biosci., Biotech. Res. Asia"},{"key":"10.1016\/j.micpath.2026.108757_bib151","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1128\/IAI.00323-09","article-title":"Urothelial cultures support intracellular bacterial community formation by uropathogenic Escherichia coli","volume":"77","author":"Berry","year":"2009","journal-title":"Infect. Immun."},{"key":"10.1016\/j.micpath.2026.108757_bib152","doi-asserted-by":"crossref","DOI":"10.1128\/iai.00509-23","article-title":"Triple threat: how diabetes results in worsened bacterial infections","volume":"92","author":"Darwitz","year":"2024","journal-title":"Infect. Immun."},{"key":"10.1016\/j.micpath.2026.108757_bib153","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3390\/pharmaceutics15010072","article-title":"Antimicrobial proteins: structure, molecular action, and therapeutic potential","volume":"15","author":"Hassan","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.micpath.2026.108757_bib154","doi-asserted-by":"crossref","DOI":"10.1111\/1751-7915.70165","article-title":"Broad\u2010spectrum antimicrobial and antibiofilm activities of halogenated anilines against uropathogenic Escherichia coli and ESKAPE pathogens","volume":"18","author":"Boya","year":"2025","journal-title":"Microb. Biotechnol."},{"key":"10.1016\/j.micpath.2026.108757_bib155","doi-asserted-by":"crossref","first-page":"8627","DOI":"10.1021\/jm101011y","article-title":"FimH antagonists for the oral treatment of urinary tract infections: from design and synthesis to in vitro and in vivo evaluation","volume":"53","author":"Klein","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.micpath.2026.108757_bib156","doi-asserted-by":"crossref","first-page":"527","DOI":"10.3390\/pharmaceutics15020527","article-title":"Insightful improvement in the design of potent uropathogenic E. coli FimH antagonists","volume":"15","author":"Mousavifar","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.micpath.2026.108757_bib157","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2026.119085","article-title":"Targeting bacterial adhesion: recent advances and therapeutic potential of FimH and PapG inhibitors against Escherichia coli infection","volume":"317","author":"Zhang","year":"2026","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.micpath.2026.108757_bib158","article-title":"Mannose derivatives as anti-infective agents","volume":"26","author":"Ribi\u0107","year":"2025","journal-title":"IJMS"},{"key":"10.1016\/j.micpath.2026.108757_bib159","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/cbic.202000406","article-title":"Developments in mannose\u2010based treatments for uropathogenic escherichia coli\u2010induced urinary tract infections","volume":"22","author":"Hatton","year":"2021","journal-title":"Chembiochem"},{"key":"10.1016\/j.micpath.2026.108757_bib160","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms10738","article-title":"Catch-bond mechanism of the bacterial adhesin FimH","volume":"7","author":"Sauer","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.micpath.2026.108757_bib161","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/ea59d179-0a71-4836-86f0-8d375f5df089","article-title":"Intervening with urinary tract infections using anti-adhesives based on the crystal structure of the FimH\u2013Oligomannose-3 complex","volume":"3","author":"Wellens","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.micpath.2026.108757_bib162","doi-asserted-by":"crossref","first-page":"9390","DOI":"10.1021\/acs.jmedchem.6b00948","article-title":"Antivirulence C-Mannosides as antibiotic-sparing, oral therapeutics for urinary tract infections","volume":"59","author":"Mydock-McGrane","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.micpath.2026.108757_bib163","doi-asserted-by":"crossref","first-page":"4779","DOI":"10.1021\/jm100438s","article-title":"Structure-based drug design and optimization of mannoside bacterial FimH antagonists","volume":"53","author":"Han","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.micpath.2026.108757_bib164","doi-asserted-by":"crossref","first-page":"3945","DOI":"10.1021\/jm300165m","article-title":"Lead optimization studies on FimH antagonists: discovery of potent and orally bioavailable ortho-substituted biphenyl mannosides","volume":"55","author":"Han","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.micpath.2026.108757_bib165","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/cmdc.201600006","article-title":"Antivirulence isoquinolone mannosides: optimization of the biaryl aglycone for FimH lectin binding affinity and efficacy in the treatment of chronic UTI","volume":"11","author":"Jarvis","year":"2016","journal-title":"ChemMedChem"},{"key":"10.1016\/j.micpath.2026.108757_bib166","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/s41429-023-00629-8","article-title":"Antibiotics in the clinical pipeline as of December 2022","volume":"76","author":"Butler","year":"2023","journal-title":"J. Antibiot."},{"key":"10.1016\/j.micpath.2026.108757_bib167","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1021\/jm501524q","article-title":"FimH antagonists: bioisosteres to improve the in vitro and in vivo PK\/PD profile","volume":"58","author":"Kleeb","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.micpath.2026.108757_bib168","doi-asserted-by":"crossref","DOI":"10.1128\/ecosalplus.esp-0033-2018","article-title":"Therapeutic approaches targeting the assembly and function of chaperone-usher pili","volume":"8","author":"Psonis","year":"2019","journal-title":"EcoSal Plus"},{"key":"10.1016\/j.micpath.2026.108757_bib169","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adz1301","article-title":"The yeh pilus adhesin is equipped with an \u03b1-helical flap motif, which contributes to pectin adherence","volume":"12","author":"Tamadonfar","year":"2026","journal-title":"Sci. Adv."},{"key":"10.1016\/j.micpath.2026.108757_bib170","doi-asserted-by":"crossref","DOI":"10.1002\/cbic.202500433","article-title":"Beyond FimH: diversity and relevance of carbohydrate\u2010binding fimbrial proteins in Escherichia coli","volume":"26","author":"Dulawa","year":"2025","journal-title":"Chembiochem"},{"key":"10.1016\/j.micpath.2026.108757_bib171","doi-asserted-by":"crossref","first-page":"12314","DOI":"10.1021\/acs.analchem.8b04235","article-title":"Direct evaluation of live uropathogenic Escherichia coli adhesion and efficiency of antiadhesive compounds using a simple microarray approach","volume":"90","author":"Kalograiaki","year":"2018","journal-title":"Anal. Chem."},{"key":"10.1016\/j.micpath.2026.108757_bib172","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1021\/jacs.8b10736","article-title":"Binding of the bacterial adhesin FimH to its natural, multivalent high-mannose type glycan targets","volume":"141","author":"Sauer","year":"2019","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.micpath.2026.108757_bib173","doi-asserted-by":"crossref","first-page":"11369","DOI":"10.1039\/C5OB01581B","article-title":"Inhibition profiles of mono- and polyvalent FimH antagonists against 10 different Escherichia coli strains","volume":"13","author":"Chalopin","year":"2015","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.micpath.2026.108757_bib174","series-title":"Peptides: the Wave of the Future","first-page":"636","article-title":"Design, synthesis and biological evaluation of pilicides: inhibitors of pilus assembly in pathogenic bacteria","author":"Larsson","year":"2001"},{"key":"10.1016\/j.micpath.2026.108757_bib175","doi-asserted-by":"crossref","first-page":"9810","DOI":"10.1021\/jm3010338","article-title":"Target selectivity of FimH antagonists","volume":"55","author":"Scharenberg","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.micpath.2026.108757_bib176","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adp7066","article-title":"Mechanisms of uropathogenic E. coli mucosal association in the gastrointestinal tract","volume":"11","author":"Azimzadeh","year":"2025","journal-title":"Sci. Adv."},{"key":"10.1016\/j.micpath.2026.108757_bib177","doi-asserted-by":"crossref","first-page":"4522","DOI":"10.1002\/chem.201103936","article-title":"Design and synthesis of fluorescent pilicides and curlicides: bioactive tools to study bacterial virulence mechanisms","volume":"18","author":"Chorell","year":"2012","journal-title":"Chemistry A European J"},{"key":"10.1016\/j.micpath.2026.108757_bib178","doi-asserted-by":"crossref","first-page":"10106","DOI":"10.1073\/pnas.1801564115","article-title":"Phosphoethanolamine cellulose enhances curli-mediated adhesion of uropathogenic Escherichia coli to bladder epithelial cells","volume":"115","author":"Hollenbeck","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.micpath.2026.108757_bib179","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/nchembio.242","article-title":"Small-molecule inhibitors target Escherichia coli amyloid biogenesis and biofilm formation","volume":"5","author":"Cegelski","year":"2009","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.micpath.2026.108757_bib180","doi-asserted-by":"crossref","DOI":"10.1128\/ecosalplus.esp-0007-2017","article-title":"Pili assembled by the chaperone\/usher pathway in Escherichia coli and salmonella","volume":"8","author":"Werneburg","year":"2018","journal-title":"EcoSal Plus"},{"key":"10.1016\/j.micpath.2026.108757_bib181","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02038-14","article-title":"Pilicide ec240 disrupts virulence circuits in uropathogenic Escherichia coli","volume":"5","author":"Greene","year":"2014","journal-title":"mBio"},{"key":"10.1016\/j.micpath.2026.108757_bib182","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/1471-2180-13-131","article-title":"Pilicides inhibit the FGL chaperone\/usher assisted biogenesis of the Dr fimbrial polyadhesin from uropathogenic Escherichia coli","volume":"13","author":"Piatek","year":"2013","journal-title":"BMC Microbiol."},{"key":"10.1016\/j.micpath.2026.108757_bib183","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1080\/21645515.2020.1834807","article-title":"Safety and immunogenicity of an adjuvanted Escherichia coli adhesin vaccine in healthy women with and without histories of recurrent urinary tract infections: results from a first-in-human phase 1 study","volume":"17","author":"Eldridge","year":"2021","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.micpath.2026.108757_bib184","doi-asserted-by":"crossref","first-page":"19089","DOI":"10.1073\/pnas.1314395110","article-title":"Conformational inactivation induces immunogenicity of the receptor-binding pocket of a bacterial adhesin","volume":"110","author":"Kisiela","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.micpath.2026.108757_bib185","author":"Lopatto"},{"key":"10.1016\/j.micpath.2026.108757_bib186","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1126\/science.276.5312.607","article-title":"Prevention of mucosal Escherichia coli infection by fimh-adhesin-based systemic vaccination","volume":"276","author":"Langermann","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.micpath.2026.108757_bib187","doi-asserted-by":"crossref","DOI":"10.1128\/iai.00169-24","article-title":"A cynomolgus monkey E. coli urinary tract infection model confirms efficacy of new FimH vaccine candidates","volume":"92","author":"Chorro","year":"2024","journal-title":"Infect. Immun."},{"key":"10.1016\/j.micpath.2026.108757_bib188","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-73179-w","article-title":"In silico analysis and in vivo assessment of a novel epitope-based vaccine candidate against uropathogenic Escherichia coli","volume":"10","author":"Hasanzadeh","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.micpath.2026.108757_bib189","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2022.105920","article-title":"Design of a chimeric protein composed of FimH, FyuA and CNF-1 virulence factors from uropathogenic Escherichia coli and evaluation its biological activity and immunogenicity in vitro and in vivo","volume":"174","author":"Hedayat","year":"2023","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.micpath.2026.108757_bib190","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.vaccine.2012.12.059","article-title":"Vaccination with recombinant FimH fused with flagellin enhances cellular and humoral immunity against urinary tract infection in mice","volume":"31","author":"Asadi Karam","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2026.108757_bib191","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/apm.12523","article-title":"Transurethral instillation with fusion protein mrpH.FimH induces protective innate immune responses against uropathogenic Escherichia coli and Proteus mirabilis","volume":"124","author":"Habibi","year":"2016","journal-title":"APMIS"},{"key":"10.1016\/j.micpath.2026.108757_bib192","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adw0698","article-title":"Monoclonal antibodies targeting the FimH adhesin protect against uropathogenic E. coli UTI","volume":"11","author":"Lopatto","year":"2025","journal-title":"Sci. Adv."},{"key":"10.1016\/j.micpath.2026.108757_bib193","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3390\/vaccines14020146","article-title":"Immunogenicity and safety of the ExPEC9V Escherichia coli vaccine Co-Administered with a high-dose influenza vaccine in older adults: a placebo-controlled, randomized, phase 3 study","volume":"14","author":"Leroux-Roels","year":"2026","journal-title":"Vaccines"},{"key":"10.1016\/j.micpath.2026.108757_bib194","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2100018","article-title":"Sublingual MV140 for prevention of recurrent urinary tract infections","volume":"1","author":"Lorenzo-G\u00f3mez","year":"2022","journal-title":"NEJM Evid."},{"key":"10.1016\/j.micpath.2026.108757_bib195","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.euros.2024.03.010","article-title":"Reducing recurrent urinary tract infections in women with MV140 impacts personal burden of disease: secondary analyses of a randomized placebo-controlled efficacy study","volume":"63","author":"Curtis Nickel","year":"2024","journal-title":"Eur. Urol. Open Sci."},{"key":"10.1016\/j.micpath.2026.108757_bib196","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00746-17","article-title":"Context-dependent requirements for FimH and other canonical virulence factors in gut colonization by extraintestinal pathogenic Escherichia coli","volume":"86","author":"Russell","year":"2018","journal-title":"Infect. Immun."},{"key":"10.1016\/j.micpath.2026.108757_bib197","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.636377","article-title":"Considerations on D-mannose mechanism of action and consequent classification of marketed healthcare products","volume":"12","author":"Scaglione","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.micpath.2026.108757_bib198","doi-asserted-by":"crossref","first-page":"885","DOI":"10.3390\/pathogens12070885","article-title":"Effect of mannan oligosaccharides extracts in uropathogenic Escherichia coli adhesion in human bladder cells","volume":"12","author":"Faustino","year":"2023","journal-title":"Pathogens"},{"key":"10.1016\/j.micpath.2026.108757_bib199","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1080\/19390211.2021.1908480","article-title":"Differences in urinary bacterial anti-adhesion activity after intake of cranberry dietary supplements with soluble versus insoluble proanthocyanidins","volume":"19","author":"Howell","year":"2022","journal-title":"J. Diet. Suppl."},{"key":"10.1016\/j.micpath.2026.108757_bib200","doi-asserted-by":"crossref","first-page":"305","DOI":"10.51273\/esc23.25131939","article-title":"Prevalence of different serotypes of uro-pathogenic escherichia Coli(UPEC) causing recurrent urinary tract infections and the effect of cranberry extract on them","volume":"19","author":"Zia","year":"2023","journal-title":"Esculap"},{"key":"10.1016\/j.micpath.2026.108757_bib201","doi-asserted-by":"crossref","first-page":"4577","DOI":"10.3390\/molecules24244577","article-title":"Polyphenols, antioxidant, antibacterial, and biofilm inhibitory activities of peel and pulp of citrus medica L., citrus bergamia, and citrus medica cv. sal\u00f2 cultivated in southern Italy","volume":"24","author":"Fratianni","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.micpath.2026.108757_bib202","doi-asserted-by":"crossref","first-page":"421","DOI":"10.3389\/fcimb.2020.00421","article-title":"Reciprocal cooperation of type A procyanidin and nitrofurantoin against multi-drug resistant (MDR) UPEC: a pH-Dependent study","volume":"10","author":"Vasudevan","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.micpath.2026.108757_bib203","doi-asserted-by":"crossref","first-page":"8571","DOI":"10.1007\/s00253-019-10120-w","article-title":"Orthosipon stamineus extract exerts inhibition of bacterial adhesion and chaperon-usher system of uropathogenic Escherichia coli\u2014a transcriptomic study","volume":"103","author":"Beydokhti","year":"2019","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.micpath.2026.108757_bib204","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/jam.14289","article-title":"Inhibition of adhesion\u2010specific genes by Solidago virgaurea extract causes loss of Candida albicans biofilm integrity","volume":"127","author":"Chevalier","year":"2019","journal-title":"J. Appl. Microbiol."},{"key":"10.1016\/j.micpath.2026.108757_bib205","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/cbf.3788","article-title":"Aqueous Rosa damascena extract: antibacterial activity and its role of adhesion to human epithelial cells in vitro","volume":"41","author":"Alsafi","year":"2023","journal-title":"Cell Biochem. Funct."},{"key":"10.1016\/j.micpath.2026.108757_bib206","doi-asserted-by":"crossref","first-page":"823","DOI":"10.3389\/fmicb.2020.00823","article-title":"Effect of Adiantum philippense extract on biofilm formation, adhesion with its antibacterial activities against foodborne pathogens, and characterization of bioactive metabolites: an in vitro-in silico approach","volume":"11","author":"Adnan","year":"2020","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.micpath.2026.108757_bib207","doi-asserted-by":"crossref","first-page":"A273.2","DOI":"10.1136\/gutjnl-2014-307263.586","article-title":"PTH-140 soluble plantain fibre inhibits the epithelial adhesion of diarrhoeal pathogens Clostridium Difficile, salmonella and enterotoxigenic E. Coli (etec) through interaction with the intestinal epithelium","volume":"63","author":"Simpson","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.micpath.2026.108757_bib208","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12937-022-00769-x","article-title":"Role of D-mannose in urinary tract infections \u2013 a narrative review","volume":"21","author":"Ala-Jaakkola","year":"2022","journal-title":"Nutr. J."},{"key":"10.1016\/j.micpath.2026.108757_bib209","article-title":"Cranberries for preventing urinary tract infections","volume":"2023","author":"Williams","year":"2023","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.micpath.2026.108757_bib210","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1016\/j.juro.2007.01.114","article-title":"Cranberry products inhibit adherence of P-Fimbriated Escherichia coli to primary cultured bladder and vaginal epithelial cells","volume":"177","author":"Gupta","year":"2007","journal-title":"J. Urol."},{"key":"10.1016\/j.micpath.2026.108757_bib211","doi-asserted-by":"crossref","DOI":"10.1128\/iai.00080-24","article-title":"Plant phenolics inhibit focal adhesion kinase and suppress host cell invasion by uropathogenic Escherichia coli","volume":"92","author":"Lewis","year":"2024","journal-title":"Infect. Immun."},{"key":"10.1016\/j.micpath.2026.108757_bib212","doi-asserted-by":"crossref","first-page":"502","DOI":"10.3390\/microorganisms12030502","article-title":"The efficacy of selected probiotic strains and their combination to inhibit the interaction of adherent-invasive Escherichia coli (AIEC) with a Co-Culture of Caco-2:HT29-MTX cells","volume":"12","author":"Bradford","year":"2024","journal-title":"Microorganisms"},{"key":"10.1016\/j.micpath.2026.108757_bib213","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/jam.13078","article-title":"Escherichia coli biofilm: development and therapeutic strategies","volume":"121","author":"Sharma","year":"2016","journal-title":"J. Appl. Microbiol."},{"key":"10.1016\/j.micpath.2026.108757_bib214","series-title":"Carbohydrate Chemistry","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1039\/9781839164538-00519","article-title":"FimH antagonists prevent biofilm formation on catheter surfaces","author":"Carere-Sigl","year":"2021"},{"key":"10.1016\/j.micpath.2026.108757_bib215","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a010306","article-title":"Bacterial biofilms: development, dispersal, and therapeutic strategies in the dawn of the postantibiotic era","volume":"3","author":"Kostakioti","year":"2013","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.micpath.2026.108757_bib216","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3003021","article-title":"Treatment and prevention of urinary tract infection with orally active FimH inhibitors","volume":"3","author":"Cusumano","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.micpath.2026.108757_bib217","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.930624","article-title":"Cinnamomum: the new therapeutic agents for inhibition of bacterial and fungal biofilm-associated infection","volume":"12","author":"Didehdar","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.micpath.2026.108757_bib218","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-23647-2","article-title":"Anti-biofilm activity of caffeine against uropathogenic E. coli is mediated by curli biogenesis","volume":"12","author":"Rathi","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.micpath.2026.108757_bib219","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.22207\/JPAM.17.4.37","article-title":"The efficacy of silver nanoparticles in combating biofilm formation by uropathogenic Escherichia coli","volume":"17","author":"Jadhav","year":"2023","journal-title":"J. Pure Appl. Microbiol."},{"key":"10.1016\/j.micpath.2026.108757_bib220","doi-asserted-by":"crossref","DOI":"10.1016\/j.micres.2023.127537","article-title":"Antimicrobial and antibiofilm activities of chromone derivatives against uropathogenic Escherichia coli","volume":"278","author":"Boya","year":"2024","journal-title":"Microbiol. Res."},{"key":"10.1016\/j.micpath.2026.108757_bib221","doi-asserted-by":"crossref","first-page":"9272","DOI":"10.1038\/s41598-023-36343-6","article-title":"Designed \u03b1-sheet peptides disrupt uropathogenic E. coli biofilms rendering bacteria susceptible to antibiotics and immune cells","volume":"13","author":"Bleem","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.micpath.2026.108757_bib222","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.5897\/AJMR2017.8700","article-title":"Effect of EDTA on biofilm formation and antibiotic susceptibility of multidrug resistant uropathogenic Escherichia coli clinical isolates in Egypt","volume":"11","author":"Wesam","year":"2017","journal-title":"Afr. J. Microbiol. Res."},{"key":"10.1016\/j.micpath.2026.108757_bib223","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1177\/039139880903200901","article-title":"New concepts and new weapons in implant infections","volume":"32","author":"Arciola","year":"2009","journal-title":"Int. J. Artif. Organs"},{"key":"10.1016\/j.micpath.2026.108757_bib224","doi-asserted-by":"crossref","first-page":"668","DOI":"10.3390\/pathogens13080668","article-title":"Aggregatibacter actinomycetemcomitans dispersin B: the quintessential antibiofilm enzyme","volume":"13","author":"Kaplan","year":"2024","journal-title":"Pathogens"},{"key":"10.1016\/j.micpath.2026.108757_bib225","doi-asserted-by":"crossref","first-page":"652","DOI":"10.3390\/biom10040652","article-title":"Antimicrobial and antibiofilm peptides","volume":"10","author":"Di Somma","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.micpath.2026.108757_bib226","doi-asserted-by":"crossref","DOI":"10.1016\/j.ecoenv.2023.115389","article-title":"Bacterial biofilm inhibitors: an overview","volume":"264","author":"Kalia","year":"2023","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"10.1016\/j.micpath.2026.108757_bib227","doi-asserted-by":"crossref","first-page":"884","DOI":"10.3390\/microorganisms10050884","article-title":"Mechanisms of inhibition of quorum sensing as an alternative for the control of E. coli and salmonella","volume":"10","author":"Escobar-Muci\u00f1o","year":"2022","journal-title":"Microorganisms"},{"key":"10.1016\/j.micpath.2026.108757_bib228","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.3389\/fmicb.2017.02599","article-title":"Low concentrations of vitamin C reduce the synthesis of extracellular polymers and destabilize bacterial biofilms","volume":"8","author":"Pandit","year":"2017","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.micpath.2026.108757_bib229","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.2174\/1568026618666181022120711","article-title":"RNAIII inhibiting peptide (RIP) and derivatives as potential tools for the treatment of S. aureus biofilm infections","volume":"18","author":"Ciulla","year":"2019","journal-title":"CTMC"},{"key":"10.1016\/j.micpath.2026.108757_bib230","doi-asserted-by":"crossref","first-page":"5363","DOI":"10.1128\/AAC.03163-14","article-title":"A broad-spectrum antibiofilm peptide enhances antibiotic action against bacterial biofilms","volume":"58","author":"Reffuveille","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2026.108757_bib231","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3390\/antibiotics13040343","article-title":"A comprehensive review of recent research into the effects of antimicrobial peptides on biofilms\u2014January 2020 to September 2023","volume":"13","author":"Fontanot","year":"2024","journal-title":"Antibiotics"},{"key":"10.1016\/j.micpath.2026.108757_bib232","doi-asserted-by":"crossref","first-page":"764","DOI":"10.3390\/antibiotics13080764","article-title":"Antimicrobial properties and cytotoxicity of LL-37-Derived synthetic peptides to treat orthopedic infections","volume":"13","author":"Pennone","year":"2024","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.micpath.2026.108757_bib233","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.3390\/ph14121245","article-title":"Structure and activity of a selective antibiofilm peptide SK-24 derived from the NMR structure of human Cathelicidin LL-37","volume":"14","author":"Zhang","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.micpath.2026.108757_bib234","doi-asserted-by":"crossref","DOI":"10.2174\/0118715265324950241204182204","article-title":"Exploration of phytochemicals as anti-biofilm agents against pathogenic bacteria: their potential and challenges","volume":"25","author":"Banerjee","year":"2025","journal-title":"IDDT"},{"key":"10.1016\/j.micpath.2026.108757_bib235","doi-asserted-by":"crossref","first-page":"607","DOI":"10.3390\/ijms26020607","article-title":"Potential use of selected natural compounds with anti-biofilm activity","volume":"26","author":"Fydrych","year":"2025","journal-title":"IJMS"},{"key":"10.1016\/j.micpath.2026.108757_bib236","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.36953\/ECJ.30601324","article-title":"Effectiveness & mechanism of phytoconstituents against Candida biofilm","volume":"25","author":"Jha","year":"2024","journal-title":"ECJ"},{"key":"10.1016\/j.micpath.2026.108757_bib237","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.3390\/antibiotics11091223","article-title":"Evaluation of Catechin synergistic and antibacterial efficacy on biofilm formation and acrA gene expression of uropathogenic E. coli clinical isolates","volume":"11","author":"Jubair","year":"2022","journal-title":"Antibiotics"},{"key":"10.1016\/j.micpath.2026.108757_bib238","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1172\/JCI20074","article-title":"Pharmacological inhibition of quorum sensing for the treatment of chronic bacterial infections","volume":"112","author":"Hentzer","year":"2003","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.micpath.2026.108757_bib239","article-title":"biofilm formation and antibiotic susceptibility of uropathogens in patients with catheter associated urinary tract infections IN IBB city -Yemen","author":"Saleh","year":"2019","journal-title":"Univ. J. Pharm. Res."},{"key":"10.1016\/j.micpath.2026.108757_bib240","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12941-021-00433-y","article-title":"Bacteriophage therapy for inhibition of multi drug\u2010resistant uropathogenic bacteria: a narrative review","volume":"20","author":"Chegini","year":"2021","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"key":"10.1016\/j.micpath.2026.108757_bib241","doi-asserted-by":"crossref","DOI":"10.1128\/msphere.00345-22","article-title":"Phage resistance accompanies reduced fitness of uropathogenic Escherichia coli in the urinary environment","volume":"7","author":"Zulk","year":"2022","journal-title":"mSphere"},{"key":"10.1016\/j.micpath.2026.108757_bib242","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1086\/345879","article-title":"Use of the quorum\u2010sensing inhibitor RNAIII\u2010Inhibiting peptide to prevent biofilm formation in vivo by drug\u2010resistant Staphylococcus epidermidis","volume":"187","author":"Balaban","year":"2003","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.micpath.2026.108757_bib243","article-title":"Development of phage cocktails to treat E. coli catheter-associated urinary tract infection and associated biofilms","volume":"13","author":"Sanchez","year":"2022","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.micpath.2026.108757_bib244","doi-asserted-by":"crossref","DOI":"10.3389\/abp.2025.14264","article-title":"Phages as potential life-saving therapeutic option in the treatment of multidrug-resistant urinary tract infections","volume":"72","author":"Zalewska-Pi\u0105tek","year":"2025","journal-title":"Acta Biochim. Pol."},{"key":"10.1016\/j.micpath.2026.108757_bib245","first-page":"112","article-title":"Phage therapy in the management of urinary tract infections: a comprehensive systematic review","volume":"4","author":"Al-Anany","year":"2023","journal-title":"PHAGE"},{"key":"10.1016\/j.micpath.2026.108757_bib246","doi-asserted-by":"crossref","first-page":"9915","DOI":"10.1007\/s00253-014-6169-6","article-title":"Microbial biofilms: biosurfactants as antibiofilm agents","volume":"98","author":"Banat","year":"2014","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.micpath.2026.108757_bib247","doi-asserted-by":"crossref","first-page":"646","DOI":"10.3390\/fermentation9070646","article-title":"Biofilm inhibition, antibacterial and antiadhesive properties of a novel biosurfactant from Lactobacillus paracasei N2 against multi-antibiotics-resistant pathogens isolated from braised fish","volume":"9","author":"Mouafo","year":"2023","journal-title":"Fermentation"},{"key":"10.1016\/j.micpath.2026.108757_bib248","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s00253-009-1987-7","article-title":"Anti-adhesion activity of two biosurfactants produced by bacillus spp. prevents biofilm formation of human bacterial pathogens","volume":"83","author":"Rivardo","year":"2009","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.micpath.2026.108757_bib249","author":"Ravishankar"},{"key":"10.1016\/j.micpath.2026.108757_bib250","doi-asserted-by":"crossref","first-page":"128","DOI":"10.18051\/UnivMed.2023.v42.128-136","article-title":"Repurposing of fluoxetine for antibacterial activities in catheter-associated urinary tract biofilm infections: an in vitro analysis","volume":"42","author":"Poyil","year":"2023","journal-title":"Univ. Med."},{"key":"10.1016\/j.micpath.2026.108757_bib251","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2022.105665","article-title":"Repurposing of FDA approved drugs against uropathogenic escherichia coli: in silico, in vitro, and in vivo analysis","volume":"169","author":"Kaur","year":"2022","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.micpath.2026.108757_bib252","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/jam.14312","article-title":"Repurposing auranofin to combat uropathogenic Escherichia coli biofilms","volume":"127","author":"Jang","year":"2019","journal-title":"J. Appl. Microbiol."},{"key":"10.1016\/j.micpath.2026.108757_bib253","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1093\/jac\/dkx151","article-title":"Repurposing of nucleoside- and nucleobase-derivative drugs as antibiotics and biofilm inhibitors","volume":"72","author":"Yssel","year":"2017","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.micpath.2026.108757_bib254","doi-asserted-by":"crossref","first-page":"344","DOI":"10.3390\/cells12030344","article-title":"Accessing the in vivo efficiency of clinically isolated phages against uropathogenic and invasive biofilm-forming Escherichia coli strains for phage therapy","volume":"12","author":"Sanmukh","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.micpath.2026.108757_bib255","doi-asserted-by":"crossref","first-page":"742","DOI":"10.3389\/fchem.2019.00742","article-title":"Small molecule anti-biofilm agents developed on the basis of mechanistic understanding of biofilm formation","volume":"7","author":"Qvortrup","year":"2019","journal-title":"Front. Chem."},{"key":"10.1016\/j.micpath.2026.108757_bib256","doi-asserted-by":"crossref","DOI":"10.1002\/cbic.202300266","article-title":"Nordihydroguaiaretic acid (NDGA) inhibits CsgA polymerization, bacterial amyloid biogenesis, and biofilm formation","volume":"24","author":"Visser","year":"2023","journal-title":"Chembiochem"},{"key":"10.1016\/j.micpath.2026.108757_bib257","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/S1473-3099(17)30108-1","article-title":"Safety, immunogenicity, and preliminary clinical efficacy of a vaccine against extraintestinal pathogenic Escherichia coli in women with a history of recurrent urinary tract infection: a randomised, single-blind, placebo-controlled phase 1b trial","volume":"17","author":"Huttner","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.micpath.2026.108757_bib258","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.euf.2019.11.002","article-title":"Role of vaccines for recurrent urinary tract infections: a systematic review","volume":"6","author":"Prattley","year":"2020","journal-title":"Euro. Urol. Focus"},{"key":"10.1016\/j.micpath.2026.108757_bib259","doi-asserted-by":"crossref","DOI":"10.1155\/2024\/4312908","article-title":"Advances in bacterial lysate immunotherapy for infectious diseases and cancer","volume":"2024","author":"Rahman","year":"2024","journal-title":"J. Immunol. Res."}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401026004833?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401026004833?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T14:17:13Z","timestamp":1788358633000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0882401026004833"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":259,"alternative-id":["S0882401026004833"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2026.108757","relation":{},"ISSN":["0882-4010"],"issn-type":[{"value":"0882-4010","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antivirulence strategies targeting adhesion and biofilm formation in uropathogenic E. coli: Recent advances and clinical perspectives-review","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2026.108757","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108757"}}